<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although <z:hpo ids='HP_0009830'>peripheral neuropathies</z:hpo> are commonly observed in patients with non-Hodgkin's malignant <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHML), <z:e sem="disease" ids="C0018378" disease_type="Disease or Syndrome" abbrv="">Guillain-Barre syndrome</z:e> (GBS) belongs to the occasional complications of <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It appears in less than 0.3 per cent of NHML </plain></SENT>
<SENT sid="2" pm="."><plain>It is worthy of note that in the reported case there occurred three independent risk factors of <z:hpo ids='HP_0009830'>peripheral neuropathy</z:hpo>: Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, chemotherapy and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Based on clinical course, EMG finding and neuropathological examination, in spite of <z:mpath ids='MPATH_458'>normal</z:mpath> cerebrospinal fluid protein content, GBS as a paraneoplastic disorder was diagnosed </plain></SENT>
<SENT sid="4" pm="."><plain>It was assumed that chemotherapy and <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> conduced to severe <z:e sem="disease" ids="C0442874" disease_type="Disease or Syndrome" abbrv="">neuropathy</z:e> </plain></SENT>
</text></document>